Thursday 14 September 2023

Venue: Utrecht Science Park

Deadline for registration: Thursday 1 September 2023

The theme of the 2023 edition will be Mucosal Vaccination.

Previous editions covered topics like Lessons learnt from COVID-19 Vaccination, Vaccines and pathogen adaptation, Development of a COVID-19 vaccine, Structural Vaccinology, Novel Vaccine Platforms, The powerful contribution of vectors to vaccine-induced immunity, Vaccination in the Elderly, Maternal vaccination, Vector-borne diseases, Vaccines and re-emerging infections and Innovative vector approaches in vaccination.

The symposium will be open for all interested at no charge (we only ask a small compensation for lunch), it is however necessary to register below.

Program 2023

09.30      Cécile van Els, RIVM & Biomolecular Health Sciences, Veterinary Medicine, Utrecht University
09.40 Gerco den Hartog, Centre of Infectious Disease Control, RIVM, Bilthoven
"Mucosal Immunity, the very concept"
10.20 John S. Tregoning, Infectious Diseases, St. Mary's campus, Imperial College, London, UK
“Intranasal immunisation: the protective capacity of the Outer Membrane Vesicles (OMV) platform”
11.10 Break
11.30 Camille Locht, Center for Infection and Immunity of Lille, CNRS, Inserm, Institut Pasteur de Lille, University of Lille
“Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine”
12.20 Lunch break
13.20 Shuran Gong, University Medical Center Groningen
"Assessing human B cell responses to influenza vaccines and adjuvants in a PBMC-derived in vitro culture system"
13.40 Joanna Kaczorwska, RIVM Bilthoven
"Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands"
14.00 Rosanne Koutstaal, RIVM Bilthoven
"Exploring RSV-B NS1 mutants in the context of a mucosal epithelial airway model"
14.20 Wouter Jong, Abera Bioscience, Amsterdam
"Bacterial OMVs as a robust and modular platform for mucosal vaccine delivery"
14.40 Frank Wegmann, Janssen Vaccines and Prevention BV, Leiden
"Mucosal Boosting Enhances Vaccine Protection Against SARS-CoV-2 in Rhesus Macaques"
15.00 End of the Symposium